Preventing Blood Loss: The Growing Role of Antifibrinolytic Drugs in Gynecology, Surgery, and More
September 22, 2023 09:33 ET
|
Research and Markets
Dublin, Sept. 22, 2023 (GLOBE NEWSWIRE) -- The "Antifibrinolytic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
Worldwide Hemophilia Treatment Industry to 2030 - by Product, Hemophilia Type and Region
February 02, 2023 12:43 ET
|
Research and Markets
Dublin, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The "Hemophilia Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
Global Bleeding Disorders Treatment Market Report 2022: Increased Focus of Pharmaceutical Companies on Recombinant Products Creates Opportunities
September 09, 2022 07:33 ET
|
Research and Markets
Dublin, Sept. 09, 2022 (GLOBE NEWSWIRE) -- The "Global Bleeding Disorders Treatment Market By Drug Type, By Disease Type, By Distribution Channel, By End User By Region, Competition, Forecast &...
Worldwide Hematology Drugs Industry to 2030 - Players Include Novo Nordisk, Shire and Bayer Among Others
April 13, 2021 05:09 ET
|
Research and Markets
Dublin, April 13, 2021 (GLOBE NEWSWIRE) -- The "Hematology Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering. This...
Antifibrinolytic Drugs Market to Hit $19.33 Billion by 2026
March 05, 2020 10:00 ET
|
Allied Market Research
Portland, OR, March 05, 2020 (GLOBE NEWSWIRE) -- The Antifibrinolytic Drugs Market size was estimated at $13.59 billion in 2018 and is expected to hit at $19.33 billion by 2026, registering a CAGR...